You just read:

Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in Phase 2b Frozen Shoulder Syndrome Study of Collagenase Clostridium Histolyticum

News provided by

Auxilium Pharmaceuticals, Inc.

Dec 13, 2013, 06:30 ET